TFA
ASTH icon

Transamerica Financial Advisors’s Astrana Health ASTH Stock Holding History

Transamerica Financial Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9
Closed -$255 – 1927
2025
Q3 		$255 Buy
+9
New +$244 ﹤0.01% 1411

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Transamerica Financial Advisors's ASTH Position: Q4 2025 in Review

Transamerica Financial Advisors sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 9 shares — an estimated $255 sold.

Transamerica Financial Advisors first reported a position in ASTH in Q3 2025 and held it in 1 quarter. The position peaked at $255 in Q3 2025. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • Transamerica Financial Advisors reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
  • Transamerica Financial Advisors sold 9 Astrana Health shares in Q4 2025, an estimated $255.
  • Transamerica Financial Advisors first reported a position in Astrana Health in Q3 2025 and held it in 1 quarter.
  • Transamerica Financial Advisors's Astrana Health position peaked at $255 in Q3 2025.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Transamerica Financial Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.